青少年和年轻人的慢性髓性白血病:临床病理学变量和结果
Mohammad A J Abdulla1,2, Mahmood B Aldapt3, Prem Chandra4
1Department of Hematology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Oncology
|July 16, 2024
概括
患有慢性髓性白血病 (CML) 的青少年和年轻人尽管年龄较小,但表现较差. 这凸显了为这种独特的患者群体量身定制的CML管理策略的需要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床研究 临床研究
背景情况:
- 青少年和年轻人 (AYA) 是慢性髓性白血病 (CML) 诊断的独特人口组,特别是在人口年轻的地区.
- 卡塔尔的CML患者队列与全球65岁的中位数诊断年龄相比,呈现出更年轻的年龄分布.
研究的目的:
- 调查与老年患者组相比,患有CML的AYA患者的不同临床病理特征和结果.
- 解决AYA在CML研究和风险分层模型中的不足.
主要方法:
- 分析了224名CML患者的队列,包括114名AYA (年龄在15-39岁之间).
- 人口,临床参数,预后得分 (Sokal,Hasford,EUTOS,ELTS) 和分子响应率 (MMR,DMR) 在AYA和老年患者之间进行了比较.
主要成果:
- 在诊断时,AYA呈现出较高的白细胞计数,较低的血红蛋白和更大的脏大小.
- 虽然AYA的索卡尔和哈斯福德分数更好,但其主要分子响应 (MMR) 率较低,实现速度较慢.
- 深度分子响应 (DMR) 率在AYA中也较低.
结论:
- 与老年人相比,患有CML的AYA的预后较差.
- 量身定制的管理策略对于优化这种独特的AYA CML群体的结果至关重要.
更多相关视频
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
70
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Bone Marrow Sampling and Transplants
321
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
321
Disorders of Leukocytes
928
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
928
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
